6533b7dafe1ef96bd126f6bb
RESEARCH PRODUCT
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.
Edward FranekDenis XavierNana PogosovaWilliam C. CushmanJonathan E. ShawMatyas KeltaiPurnima Rao-melaciniJeffrey L. ProbstfieldHelen M. ColhounFernando T LanasLawrence A. LeiterHarpreet S. BajajLars RydénMark LakshmananIgnacio CongetMarkolf HanefeldHertzel C. GersteinPeter J RaubenheimerGilles R. DagenaisPatricio Lopez-jaramilloWayne H-h SheuJan BasileValdis Piragssubject
Blood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineEndocrinologyRandomized controlled trialDouble-Blind MethodErectile DysfunctionlawInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic Agents030212 general & internal medicineRisk factorAgedbusiness.industryIncidence (epidemiology)Middle Agedmedicine.diseasePrognosisImmunoglobulin Fc FragmentsErectile dysfunctionDiabetes Mellitus Type 2Cardiovascular DiseasesDulaglutideFemalebusinessBiomarkersmedicine.drugFollow-Up Studiesdescription
Digital
year | journal | country | edition | language |
---|---|---|---|---|
2021-08-01 | The lancet. Diabetesendocrinology |